Omeros Stock Price. Everything You Need To Know About The Omeros Stock!
Omeros Corp. operates as a biopharmaceutical company. The company is headquartered in Seattle, Washington and currently employs 196 full-time employees. The company went IPO on 2009-10-08. The company is focused on discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders, including complement-mediated diseases, cancers, and addictive and compulsive disorders. Its lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, COVID-19, and atypical hemolytic uremic syndrome. OMS906, its inhibitor of MASP-3, the key activator of the alternative pathway of complement, is advancing in clinical programs for paroxysmal nocturnal hemoglobinuria, complement 3 (C3) glomerulopathy and one or more related indications.
Omeros Stock Price. Everything You Need To Know About The Omeros Stock! performance
- Employees 196
- Company HQ Seattle
- Website https://www.omeros.com/
- OMER Asset Type Common Stock
- OMER Market Capitalization 182.5M
- Earnings Per Share -2.79
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Omeros Corporation is a promising biopharmaceutical company that focuses on developing and commercializing therapeutics for various medical conditions. With its innovative solutions and groundbreaking research, Omeros has garnered attention from retail investors in Malaysia, Thailand, Indonesia, and Vietnam. If you are interested in investing in Omeros from these countries, you have come to the right place. Zorion, the leading investment platform, provides you with the opportunity to invest in real US stocks, including Omeros. By offering investment insights and recommendations, Zorion helps you make informed decisions about your investments. Moreover, retail investors from Malaysia, Thailand, Indonesia, and Vietnam can access comprehensive resources and educational materials on Zorion to further enhance their investment knowledge. Start investing in Omeros today and reap the benefits of being ahead in the healthcare industry.
